Product Information
ABIGALE LO 0.5-0.1 MG TABLET is a generic product labeled by Xiromed LLC, priced at $0.8020 per EA under NDC 70700030385. Its NADAC has been published 60 times since Aug 13, 2025.
FDA first approved this application on Feb 10, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5; .1 mg/1; mg/1
Manufacturer
Xiromed LLCNDC
70700030385
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ESTRADIOL; NORETHINDRONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA207261FDA Approved
2/10/2017
TE Code
AB
On Market Since
1/29/2025
Price Statistics
The NADAC for ABIGALE LO 0.5-0.1 MG TABLET has been published 60 times since Aug 13, 2025, and over the history we have for it it has risen 13.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8020 per EA |
|---|---|
| All-time high | $0.9671 (Mar 11, 2026) |
| All-time low | $0.6778 (Apr 22, 2026) |
| 52-week high | $0.9671 |
| 52-week low | $0.6778 |
| Median price | $0.8163 |
| Average price | $0.8178 |
| Largest weekly change | -21.5% (Mar 18, 2026) |
| Weeks tracked | 60 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the estradiol and norethindrone acetate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xiromed LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
estradiol and norethindrone acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ABIGALE LO 0.5-0.1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ABIGALE LO 0.5-0.1 MG TABLET, manufactured by Xiromed LLC, is $0.8020 per EA (NDC 70700030385), effective Sep 30, 2026.
How has the price of ABIGALE LO 0.5-0.1 MG TABLET changed over time?
Over the history we have for it, the NADAC for ABIGALE LO 0.5-0.1 MG TABLET has risen 13.2%. It has been tracked across 60 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for ABIGALE LO 0.5-0.1 MG TABLET?
Since Aug 13, 2025, the NADAC for ABIGALE LO 0.5-0.1 MG TABLET has ranged from a low of $0.6778 (Apr 22, 2026) to a high of $0.9671 (Mar 11, 2026), with a median of $0.8163 per EA.
Are there cheaper alternatives to ABIGALE LO 0.5-0.1 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ABIGALE LO 0.5-0.1 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ABIGALE LO 0.5-0.1 MG TABLET?
ABIGALE LO 0.5-0.1 MG TABLET (NDC 70700030385) is labeled by Xiromed LLC, and CMS classifies it as a generic product.